Correlation Between Eliem Therapeutics and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Eliem Therapeutics and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Biodexa Pharmaceticals.
Diversification Opportunities for Eliem Therapeutics and Biodexa Pharmaceticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Biodexa is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Biodexa Pharmaceticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.53 times more return on investment than Biodexa Pharmaceticals. However, Eliem Therapeutics is 1.89 times less risky than Biodexa Pharmaceticals. It trades about -0.11 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.08 per unit of risk. If you would invest 766.00 in Eliem Therapeutics on August 28, 2024 and sell it today you would lose (466.00) from holding Eliem Therapeutics or give up 60.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.41% |
| Values | Daily Returns |
Eliem Therapeutics vs. Biodexa Pharmaceticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Biodexa Pharmaceticals |
Eliem Therapeutics and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Biodexa Pharmaceticals
The main advantage of trading using opposite Eliem Therapeutics and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Biodexa Pharmaceticals vs. Eliem Therapeutics | Biodexa Pharmaceticals vs. Scpharmaceuticals | Biodexa Pharmaceticals vs. Milestone Pharmaceuticals | Biodexa Pharmaceticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |